These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 23916822)
1. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822 [TBL] [Abstract][Full Text] [Related]
2. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment. Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551 [TBL] [Abstract][Full Text] [Related]
3. Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate. Wang X; Zhang Y; Huang J; Xia M; Liu L; Tian C; Hu R; Gui S; Chu X Int J Pharm; 2019 May; 562():31-41. PubMed ID: 30878587 [TBL] [Abstract][Full Text] [Related]
4. A Novel Phytantriol-Based Lyotropic Liquid Crystalline Gel for Efficient Ophthalmic Delivery of Pilocarpine Nitrate. Wang X; Zhang Y; Huang J; Tian C; Xia M; Liu L; Li Z; Cao J; Gui S; Chu X AAPS PharmSciTech; 2019 Jan; 20(1):32. PubMed ID: 30603986 [TBL] [Abstract][Full Text] [Related]
5. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263 [TBL] [Abstract][Full Text] [Related]
6. Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation. Chen Y; Lu Y; Zhong Y; Wang Q; Wu W; Gao S J Drug Target; 2012 Dec; 20(10):856-63. PubMed ID: 23050903 [TBL] [Abstract][Full Text] [Related]
7. Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation. Liu R; Wang S; Fang S; Wang J; Chen J; Huang X; He X; Liu C Nanoscale Res Lett; 2016 Dec; 11(1):254. PubMed ID: 27188974 [TBL] [Abstract][Full Text] [Related]
8. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation. Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294 [TBL] [Abstract][Full Text] [Related]
9. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Elgindy NA; Mehanna MM; Mohyeldin SM Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671 [TBL] [Abstract][Full Text] [Related]
10. Treatment for chemical burning using liquid crystalline nanoparticles as an ophthalmic delivery system for pirfenidone. Silva RO; Costa BLD; Silva FRD; Silva CND; Paiva MB; Dourado LFN; Malachias Â; Souza Araújo AA; Nunes PS; Silva-Cunha A Int J Pharm; 2019 Sep; 568():118466. PubMed ID: 31254623 [TBL] [Abstract][Full Text] [Related]
11. Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide. Verma P; Ahuja M Drug Deliv; 2016 Oct; 23(8):3043-3054. PubMed ID: 26878398 [TBL] [Abstract][Full Text] [Related]
12. [Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate]. Wei J; He HL; Zheng CL; Zhu JB Yao Xue Xue Bao; 2011 Aug; 46(8):990-6. PubMed ID: 22007526 [TBL] [Abstract][Full Text] [Related]
13. Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation. Badie H; Abbas H Drug Dev Ind Pharm; 2018 Dec; 44(12):2013-2025. PubMed ID: 30095009 [TBL] [Abstract][Full Text] [Related]
14. Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation. Wu W; Li J; Wu L; Wang B; Wang Z; Xu Q; Xin H AAPS PharmSciTech; 2013 Sep; 14(3):1063-71. PubMed ID: 23813437 [TBL] [Abstract][Full Text] [Related]
15. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine. Lai JY; Hsieh AC Biomaterials; 2012 Mar; 33(7):2372-87. PubMed ID: 22182746 [TBL] [Abstract][Full Text] [Related]
16. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles. Kao HJ; Lin HR; Lo YL; Yu SP J Pharm Pharmacol; 2006 Feb; 58(2):179-86. PubMed ID: 16451745 [TBL] [Abstract][Full Text] [Related]
17. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery. El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND Int J Pharm; 2020 May; 582():119313. PubMed ID: 32283196 [TBL] [Abstract][Full Text] [Related]
18. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. Barauskas J; Cervin C; Jankunec M; Spandyreva M; Ribokaite K; Tiberg F; Johnsson M Int J Pharm; 2010 May; 391(1-2):284-91. PubMed ID: 20214966 [TBL] [Abstract][Full Text] [Related]
19. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies. Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348 [TBL] [Abstract][Full Text] [Related]
20. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide. Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]